메뉴 건너뛰기
Current Oncology
Volumn 20, Issue 3, 2013, Pages 145-147
Salpingectomy to prevent ovarian cancer

(1)  Narod, S A a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

CANCER PREVENTION; CANCER RISK; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; MUTATIONAL ANALYSIS; NOTE; OVARIECTOMY; OVARY CANCER; PATIENT SATISFACTION; RISK ASSESSMENT; RISK FACTOR; SALPINGECTOMY; SALPINGOOOPHORECTOMY; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL APPROACH; TUMOR SUPPRESSOR GENE;
EID: 84878767687     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.20.1471     Document Type: Note
Times cited : (18)
References (8)
  • 1
    • 0028327167 scopus 로고
    • Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview
    • Kelsey JL, Whittemore AS. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview. Ann Epidemiol 1994;4:89-95.
    • (1994) Ann Epidemiol , vol.4 , pp. 89-95
    • Kelsey, J.L.1    Whittemore, A.S.2
  • 2
    • 34248574353 scopus 로고    scopus 로고
    • Ovarian cancer and hormone replacement therapy in the Million Women Study
    • Million Women Study Collaborators
    • Beral V, Million Women Study Collaborators, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369:1703-10.
    • (2007) Lancet , vol.369 , pp. 1703-1710
    • Beral, V.1    Bull, D.2    Green, J.3    Reeves, G.4
  • 4
    • 0038744296 scopus 로고    scopus 로고
    • Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
    • Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
    • (2003) Am J Hum Genet , vol.72 , pp. 1117-1130
    • Antoniou, A.1    Pharoah, P.D.2    Narod, S.3
  • 5
    • 33745881036 scopus 로고    scopus 로고
    • Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
    • Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006;296:185-92.
    • (2006) JAMA , vol.296 , pp. 185-192
    • Finch, A.1    Beiner, M.2    Lubinski, J.3
  • 6
    • 53249097506 scopus 로고    scopus 로고
    • Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
    • Eisen A, Lubinski J, Gronwald J, et al. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 2008;100:1361-7.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 1361-1367
    • Eisen, A.1    Lubinski, J.2    Gronwald, J.3
  • 7
    • 29144522408 scopus 로고    scopus 로고
    • Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutationcarriers: An international case-control study
    • Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutationcarriers: an international case-control study. J Clin Oncol 2005;23:7491-6.
    • (2005) J Clin Oncol , vol.23 , pp. 7491-7496
    • Eisen, A.1    Lubinski, J.2    Klijn, J.3
  • 8
    • 84863596964 scopus 로고    scopus 로고
    • Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    • Kotsopoulos J, Lubinski J, Lynch HT, et al. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012;21:1089-96.
    • (2012) Cancer Epidemiol Biomarkers Prev , vol.21 , pp. 1089-1096
    • Kotsopoulos, J.1    Lubinski, J.2    Lynch, H.T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.